Alpha Tau CFO exercises options and sells 17,873 shares

Alpha Tau Medical Ltd. Chief Financial Officer Raphi Levy executed an exercise-and-sell transaction in company Ordinary Shares.

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. Chief Financial Officer Raphi Levy executed an exercise-and-sell transaction in company Ordinary Shares. He exercised 17,873 shares at $2.98 per share and then sold 17,873 shares in an open-market sale at an average price of $13.0027 per share on July 2, 2026.

Following these transactions, Levy directly holds 90,180 Ordinary Shares. The pattern shows option exercise to acquire shares and a same-day sale of an equivalent number of shares, while maintaining a substantial remaining equity position.

Insights

Equity compensation and insider-trading analyst

CFO exercised options then sold an equal number of shares, retaining a sizable stake.

Raphi Levy, Chief Financial Officer of Alpha Tau Medical Ltd., exercised 17,873 Ordinary Shares at $2.98 and sold 17,873 shares at $13.0027. This is a classic exercise-and-sell pattern, converting option value into cash.

After these moves, Levy directly owns 90,180 Ordinary Shares, so the sale represents only a portion of his total holdings. With no footnote references to trading plans or special arrangements in the excerpt, the transactions appear as routine equity compensation monetization based solely on the available data.

Insider Trade Summary 10b5-1

Net Seller: 17,873 shares

Net Sell 2 txns

Insider Levy Raphi

Role Chief Financial Officer

Sold 17,873 shs ($232K)

Type	Security	Shares	Price	Value
Exercise	Ordinary Shares	17,873	$2.98	$53K
Sale	Ordinary Shares	17,873	$13.0027	$232K

Holdings After Transaction: Ordinary Shares — 90,180 shares (Direct)

Key Figures

Shares sold: 17,873 Ordinary Shares Sale price: $13.0027 per share Shares exercised: 17,873 Ordinary Shares +2 more

5 metrics

Shares sold 17,873 Ordinary Shares Open-market sale on July 2, 2026

Sale price $13.0027 per share Average sale price for 17,873 shares

Shares exercised 17,873 Ordinary Shares Derivative exercise/conversion on July 2, 2026

Exercise price $2.98 per share Price for exercised 17,873 shares

Shares held after sale 90,180 Ordinary Shares Direct ownership after reported transactions

Key Terms

open-market sale, derivative exercise/conversion, Ordinary Shares, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What did Alpha Tau Medical (DRTS) CFO Raphi Levy do in this Form 4 filing?

Raphi Levy exercised 17,873 Ordinary Shares at $2.98 and sold 17,873 shares at $13.0027 on July 2, 2026. This reflects an exercise-and-sell transaction while retaining a significant remaining share position.

How many Alpha Tau Medical (DRTS) shares did the CFO sell and at what price?

The CFO sold 17,873 Ordinary Shares in an open-market transaction at an average price of $13.0027 per share. This sale followed the exercise of 17,873 shares acquired at a lower exercise price of $2.98 per share.

How many Alpha Tau Medical (DRTS) shares does Raphi Levy hold after these transactions?

After the reported transactions, Raphi Levy directly holds 90,180 Ordinary Shares. This figure reflects his position following the exercise of 17,873 shares and the same-day sale of 17,873 shares disclosed in the Form 4 filing.

What type of transactions are reported in Alpha Tau Medical (DRTS) CFO’s Form 4?

The Form 4 shows a derivative exercise/conversion and an open-market sale. Levy exercised 17,873 shares at $2.98 and sold 17,873 shares at $13.0027, a common pattern where options are exercised and an equal number of shares are sold.

Does the Alpha Tau Medical (DRTS) Form 4 indicate routine compensation activity for the CFO?

The filing reflects an exercise of 17,873 shares at $2.98 followed by an equal-sized sale at $13.0027, with 90,180 shares still held. This structure is consistent with monetizing equity compensation while maintaining an ongoing ownership stake.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 11:37 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Raphi

(Last) (First) (Middle)

C/O ALPHA TAU MEDICAL

PO BOX 45044

(Street)

JERUSALEM 9777605

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/02/2026	07/02/2026	M		17,873	A	$2.98	108,053	D
Ordinary Shares	07/02/2026	07/02/2026	S		17,873	D	$13.0027	90,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Raphi Levy	07/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)